Page 2 - Stem Cell Based Therapy News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Hits: 845
TUCSON, AZ, USA I December 8, 2020 I Procyon Technologies LLC today announced that it has entered into an exclusive research collaboration and license agreement with Novo Nordisk A/S to develop an implantable cell encapsulation device to be used in Novo Nordisk s development of a novel therapy for Type 1 diabetes.
The collaboration brings together Procyon Technologies expertise with development of oxygen enabled implantable cell encapsulation devices and Novo Nordisk s expertise in stem cell-derived insulin-secreting cells.
The partners will work together to further optimize the device and cells for clinical testing and accelerate the path to First Human Dose with the joint vision of delivering a functional cure for people living with Type 1 diabetes. ....

Jacob Sten Petersen , Michael Mi Abecassis , Esther Latres , Klearchos Papas , Taylors Riall , Novo Nordisk , National Institute Of Diabetes , I Procyon Technologies , Uarizona College Of Medicine , Uarizona Department Of Surgery , Department Of Surgery , Procyon Technologies , Institute For Cellular Transplantation , University Of Arizona , University Of Arizona College Medicine , Stem Cell Based Therapy , United Statesi December , Procyon Technologie , First Human Dose , Arizona College , Cellular Transplantation , National Institute , Kidney Diseases , ஜாகோப் ஸ்டென் பீட்டர்சன் , மைக்கேல் மை , தேசிய நிறுவனம் ஆஃப் நீரிழிவு நோய் ,